D.E. Shaw & Co’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Sell |
6,540,785
-362,698
| -5% | -$1.15M | 0.01% | 1228 |
|
|
2025
Q4 | $25.5M | Buy |
6,903,483
+6,694,850
| +3,209% | +$21.6M | 0.02% | 1089 |
|
|
2025
Q3 | $553K | Buy |
+208,633
| New | +$404K | ﹤0.01% | 3814 |
|
|
2025
Q2 | – | Sell |
-275,707
| Closed | -$397K | – | 4470 |
|
|
2025
Q1 | $397K | Buy |
275,707
+24,115
| +10% | +$44.4K | ﹤0.01% | 3619 |
|
|
2024
Q4 | $554K | Buy |
251,592
+152,019
| +153% | +$355K | ﹤0.01% | 3551 |
|
|
2024
Q3 | $164K | Sell |
99,573
-282,915
| -74% | -$571K | ﹤0.01% | 4187 |
|
|
2024
Q2 | $849K | Sell |
382,488
-4,760,998
| -93% | -$11.2M | ﹤0.01% | 3285 |
|
|
2024
Q1 | $13.8M | Buy |
5,143,486
+3,930,283
| +324% | +$9.55M | 0.02% | 1154 |
|
|
2023
Q4 | $3.63M | Buy |
+1,213,203
| New | +$1.57M | 0.01% | 2177 |
|
|
2022
Q4 | – | Sell |
-351,039
| Closed | -$2.35M | – | 4937 |
|
|
2022
Q3 | $2.35M | Sell |
351,039
-352,439
| -50% | -$2.42M | ﹤0.01% | 2851 |
|
|
2022
Q2 | $4.47M | Buy |
703,478
+66,042
| +10% | +$374K | 0.01% | 2260 |
|
|
2022
Q1 | $2.96M | Sell |
637,436
-247,036
| -28% | -$1.06M | ﹤0.01% | 2913 |
|
|
2021
Q4 | $4.42M | Buy |
884,472
+861,393
| +3,732% | +$6.9M | 0.01% | 2517 |
|
|
2021
Q3 | $278K | Buy |
+23,079
| New | +$336K | ﹤0.01% | 4403 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4177 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3995 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3939 |
|
|
2020
Q2 | – | Sell |
-7,125
| Closed | -$298K | – | 4069 |
|
|
2020
Q1 | $225K | Sell |
7,125
-40,850
| -85% | -$2.16M | ﹤0.01% | 3595 |
|
|
2019
Q4 | $2.86M | Buy |
47,975
+17,885
| +59% | +$804K | ﹤0.01% | 2185 |
|
|
2019
Q3 | $1.1M | Buy |
30,090
+19,056
| +173% | +$755K | ﹤0.01% | 2774 |
|
|
2019
Q2 | $514K | Buy |
+11,034
| New | +$518K | ﹤0.01% | 3065 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3701 |
|
|
2018
Q4 | – | Sell |
-17,797
| Closed | -$857K | – | 3834 |
|
|
2018
Q3 | $790K | Buy |
+17,797
| New | +$817K | ﹤0.01% | 2827 |
|
|
2018
Q2 | – | Sell |
-19,434
| Closed | -$982K | – | 3751 |
|
|
2018
Q1 | $1.41M | Buy |
19,434
+8,978
| +86% | +$659K | ﹤0.01% | 2271 |
|
|
2017
Q4 | $688K | Buy |
+10,456
| New | +$563K | ﹤0.01% | 2789 |
|
|
2017
Q1 | – | Sell |
-24,796
| Closed | -$310K | – | 3387 |
|
|
2016
Q4 | $310K | Sell |
24,796
-27,543
| -53% | -$328K | ﹤0.01% | 3104 |
|
|
2016
Q3 | $725K | Buy |
+52,339
| New | +$593K | ﹤0.01% | 2599 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3855 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3766 |
|
|
2015
Q2 | – | Sell |
-6,047
| Closed | -$592K | – | 3773 |
|
|
2015
Q1 | $560K | Buy |
+6,047
| New | +$390K | ﹤0.01% | 2985 |
|
Other funds holding ESPR
WA
TSC
O
VCM
ACM